Trump Administration Halts Plan to Sideline Pharmacy Benefit Managers

The White House abandoned a push to end rebates paid to middlemen who negotiate drug prices on behalf of health insurers, a move that could turn scrutiny back on how drugmakers themselves set prices. President Donald Trump has made lowering …
Source: Insurance News

Leave Comment

Your email address will not be published. Required fields are marked *